Market Overview

ICYMI: MicroCap Trading Ideas, Puma Biotech, A Valeant Bear Call

Share:
ICYMI: MicroCap Trading Ideas, Puma Biotech, A Valeant Bear Call
Related VRX
60 Biggest Movers From Yesterday
The Week Ahead: Pharma IPOs Galore, Blackberry Earnings And More
Valeant -2.8% as TD Securities cuts to Hold (Seeking Alpha)
Related VUZI
25 Stocks Moving In Friday's Pre-Market Session
36 Biggest Movers From Yesterday

In case you missed it, here are some of Benzinga's top stories from Wednesday, Jan. 24, 2018.

A Pharma Trade From Goldman

Jayson Derrick outlines a bull and bear call on Catelent, Inc (NYSE: CTLT) and Valeant Pharmaceuticals International, Inc (NYSE: VRX), respectively, from Goldman Sachs. Check out “Goldman Sachs On Specialty Pharma: Buy Catalent, Sell Valeant.”

Puma Biotech Declawed By European Medicines Agency

Puma Biotechnology, Inc (NASDAQ: PBYI) shares were crushed Wednesday after reporting a negative trend vote from European regulators regarding its neratinib compound. Learn more in Shanthi Rexaline’s “What You Need to Know About Puma Biotech's 25% Slide.”

Related Link: With EU Approval For Puma Biotech's Breast Cancer Drug Unlikely, Cowen Downgrades

'3 Micro-Cap Tech Stocks To Watch In 2018'

Bill Haddad checked out the LD Micro Virtual CES Wrap Up so that you don’t have to. From Vuzix Corporation (NASDAQ: VUZI) to My Size, Inc (NASDAQ: MYSZ), learn why these names are worth keeping an eye on this year.

Latest Ratings for VRX

DateFirmActionFromTo
Jun 2018TD SecuritiesDowngradesBuyHold
Jun 2018BarclaysUpgradesEqual-WeightOverweight
May 2018MizuhoUpgradesNeutralBuy

View More Analyst Ratings for VRX
View the Latest Analyst Ratings

Posted-In: Analyst Color Biotech News Previews Small Cap After-Hours Center Analyst Ratings Trading Ideas Best of Benzinga

 

Related Articles (CTLT + MYSZ)

View Comments and Join the Discussion!